Pregled bibliografske jedinice broj: 685260
Peripheral facial weakness (bell’s palsy)
Peripheral facial weakness (bell’s palsy) // Acta clinica Croatica, 52 (2013), 2; 195-202 (međunarodna recenzija, pregledni rad, znanstveni)
CROSBI ID: 685260 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Peripheral facial weakness (bell’s palsy)
Autori
Bašić-Kes, Vanja ; Đermanović Dobrota, Vesna ; Cesarik, Marijan ; Zadro Matovina, Lucija ; Madžar, Zrinko ; Zavoreo, Iris ; Demarin, Vida
Izvornik
Acta clinica Croatica (0353-9466) 52
(2013), 2;
195-202
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni
Ključne riječi
Bell palsy – diagnosis ; Bell palsy – therapy ; Acupuncture
Sažetak
Peripheral facial weakness is a facial nerve damage that results in muscle weakness on one side of the face. It may be idiopathic (Bell’s palsy) or may have a detectable cause. Almost 80% of peripheral facial weakness cases are primary and the rest of them are secondary. The most frequent causes of secondary peripheral facial weakness are systemic viral infections, trauma, surgery, diabetes, local infections, tumor, immune disorders, drugs, degenerative diseases of the central nervous system, etc. The diagnosis relies upon the presence of typical signs and symptoms, blood chemistry tests, cerebrospinal fluid investigations, nerve conduction studies and neuroimaging methods (cerebral MRI, x-ray of the skull and mastoid). Treatment of secondary peripheral facial weakness is based on therapy for the underlying disorder, unlike the treatment of Bell’s palsy that is controversial due to the lack of large, randomized, controlled, prospective studies. There are some indications that steroids or antiviral agents are beneficial but there are also studies that show no beneficial effect. Additional treatments include eye protection, physiotherapy, acupuncture, botulinum toxin, or surgery. Bell’s palsy has a benign prognosis with complete recovery in about 80% of patients, 15% experience some mode of permanent nerve damage and severe consequences remain in 5% of patients.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Opća županijska bolnica Požega
Profili:
Vida Demarin
(autor)
Zrinko Madžar
(autor)
Vesna Đermanović Dobrota
(autor)
Vanja Bašić Kes
(autor)
Marijan Cesarik
(autor)
Lucija Zadro
(autor)
Iris Zavoreo
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE